leqembi - myDSC

Resources for Professionals

Resources for Professionals

LuMind IDSC Statement on FDA Approval of Leqembi

Last week the FDA announced a full approval of a new drug called Leqembi to…

Kim WarrenJuly 13, 2023

Resources for Professionals

Resources for Professionals

Adapting Eligibility Criteria for Prescribing FDA Approved Anti-amyloid Immunotherapeutics for Adults with Down Syndrome with Early-Stage Alzheimer’s Dementia

An international group of experts convened to determine prescribing criteria equivalences that would be inclusionary…

Kim WarrenJune 2, 2023

© 2025 myDSC.